The antibiotic therapy of community-acquired peritonitis;Antibiothérapie des péritonites communautaires

Annales Francaises d'Anesthesie et de Reanimation

Volumn 20, Issue SUPPL. 2, 2001, Pages 411-426

  Montravers, P ^a  

^a AMIENS UNIVERSITY HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

AMINOGLYCOSIDE ANTIBIOTIC AGENT; ANTIBIOTIC AGENT; BETA LACTAM ANTIBIOTIC; CARBAPENEM DERIVATIVE; CEFEPIME; CEFOPERAZONE; CEFOTAXIME; CEFOXITIN; CEFTRIAXONE; CEFUROXIME; CEPHALOSPORIN DERIVATIVE; CEPHAMYCIN DERIVATIVE; CIPROFLOXACIN; CLINDAMYCIN; GENTAMICIN; IMIPENEM; LATAMOXEF; METRONIDAZOLE; MONOBACTAM DERIVATIVE; NETILMICIN; PEFLOXACIN; PENICILLIN DERIVATIVE; PIPERACILLIN; PIPERACILLIN PLUS TAZOBACTAM; QUINOLINE DERIVED ANTIINFECTIVE AGENT; SULTAMICILLIN; TOBRAMYCIN; TROVAFLOXACIN; UNINDEXED DRUG; UREIDOPENICILLIN DERIVATIVE;

ANTIBIOTIC THERAPY; BACTERIAL PERITONITIS; CLINICAL EXAMINATION; CONFERENCE PAPER; DRUG CHOICE; DRUG INDICATION; HUMAN; MEDICAL DECISION MAKING; TREATMENT PLANNING;

ANTI-BACTERIAL AGENTS; COMMUNITY-ACQUIRED INFECTIONS; HUMANS; PERITONITIS;

EID: 0035659941     PISSN: 07507658     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (130)

1. Guidelines for the evaluation of anti-infective drug products
2. European guidelines for anti-infective drug products
3. General guidelines for the evaluation of new anti-infective drugs for the treatment of intra-abdominal and pelvic infections
4. A comparison of imipenem/cilastatin with the combination of cefuroxime and metronidazole in the treatment of intra-abdominal infections
5. A randomized, double-blind clinical trial comparing cefepime plus metronidazole with imipenem-cilastatin in the treatment of complicated intra-abdominal infections
6. Prospective, randomized comparison of metronidazole and clindamycin, each with gentamicin, for the treatment of serious intra-abdominal infection
7. Management of intra-abdominal infections
8. Meta-analysis of the clinical outcome of carbapenem monotherapy in the adjunctive treatment of intra-abdominal infections
9. Meropenem versus tobramycin plus clindamycin for treatment of intra-abdominal infections: Results of a prospective, randomized, double-blind clinical trial
10. Meropenem monotherapy versus cefotaxime plus metronidazole combination treatment for serious intra-abdominal infections
11. Comparacion prospectiva, aleatoria y abierta de meropenem frente a cefotaxima y metronidazol en el tratamiento de las infecciones intra-abdominales
12. Results of a multicenter trial comparing imipenem/cilastatin to tobramycin/clindamycin for intra-abdominal infections
13. Results of a randomized trial comparing sequential intravenous/oral treatment with ciprofloxacin plus metronidazole to imipenem/cilastatin for intra-abdominal infections
14. Imipenem-cilastatin vs tobramycin and metronidazole for appendicitis-related infections
15. Efficacy of a beta-lactamase inhibitor combination for serious intra-abdominal infections
16. Results of a randomized, multicenter trial of meropenem versus clindamycin/tobramycin for the treatment of intra-abdominal infections
17. Meropenem (1.5 g/day) is as effective as imipenem/cilastatin (2 g/day) for the treatment of moderately severe intra-abdominal infections
18. Pseudomonas aeruginosa as a primary pathogen in children with bacterial peritonitis
19. Can oral metronidazole substitute parenteral drug therapy in acute appendicitis? A new policy in the management of simple or complicated appendicitis with localized peritonitis: A randomized controlled clinical trial
20. Clindamycin plus amikacin versus clindamycin plus aztreonam in established intra-abdominal infections
21. Comparaison de deux associations d'antibiotiques au cours des péritonites: Céfotaxime + clindamycine versus céfotaxime + métronidazole
22. Imipenem/cilastatin (1.5 g daily) versus meropenem (3.0 g daily) in patients with intra-abdominal infections: Results of a prospective, randomized, multicenter trial
23. Antibiotic management of surgically treated gangrenous or perforated appendicitis. Comparison of gentamicin and clindamycin versus cefamandole versus cefoperazone
24. Surgically treated gangrenous or perforated appendicitis - A comparison of aztreonam and clindamycin versus gentamicin and clindamycin
25. A clinical comparison of cefepime and metronidazole versus gentamicin and clindamycin in the antibiotic management of surgically treated advanced appendicitis
26. Aztreonam plus clindamycin vs. tobramycin plus clindamycin for the treatment of intra-abdominal infections
27. Short-term antibiotherapy for peritonitis: Prospective, randomized trial comparing cefotaxime-metronidazole and clindamycin-tobramycin
28. Piperacillin-tazobactam versus imipenem-cilastatin for treatment of intra-abdominal infections
29. Traitement empirique des infections intra-abdominales sévères: Étude multicentrique comparative de l'efficacité de l'imipenem/cilastatine et de la ceftazidime
30. Ceftazidime/clindamycin versus tobramycin/clindamycin in the treatment of intra-abdominal infections
31. A comparative study of cefamandole versus gentamicin plus clindamycin in the treatment of documented or suspected bacterial peritonitis
32. Comparison of imipenem/cilastatin with the combination of aztreonam and clindamycin in the treatment of intra-abdominal infections
33. Trovafloxacin in the treatment of intra-abdominal infections: Results of a double-blind, multicenter comparison with imipenem/cilastatin
34. Ticarcillin/clavulanate compared with clindamycin/gentamicin (with or without ampicillin) for the treatment of intra-abdominal infections in pediatric and adult patients
35. A prospective randomized controlled trial of cefoxitin versus clindamycin-aminoglycoside in mixed anaerobic-aerobic infections
36. Efficacy of two comparative antibiotic regimens in the treatment of serious intra-abdominal infections: Results of a multicenter study
37. A randomized multicenter trial of piperacillin/tazobactam versus imipenem/cilastatin in the treatment of severe intra-abdominal infections
38. Antibiotic therapy of intra-abdominal sepsis in the elderly: Experience with ticarcillin and clavulanic acid
39. Imipenem (N-F-thienamycin) versus netilmicin plus clindamycin. A controlled and randomized comparison in intra-abdominal infections
40. Comparison of cefoperazone plus sulbactam with clindamycin plus gentamicin as treatment for intra-abdominal infections
41. Results of the North American trial of piperacillin/tazobactam compared with clindamycin and gentamicin in the treatment of severe intra-abdominal infections
42. Study of appendicitis in children treated with four different antibiotic regimens
43. Comparative study of netilmicin/tinidazole versus netilmicin/clindamycin in the treatment of severe abdominal infections
44. A multicentric study of netilmicin once daily versus thrice daily in patients with appendicitis and other intra-abdominal infections
45. Ciprofloxacin vs. cefotaxime regimens for the treatment of intraabdominal infections
46. Susceptibility of intra-abdominal isolates at operation: A predictor of postoperative infection
47. Management of severe intra-abdominal sepsis: Single agent antibiotic therapy with cefotetan versus combination therapy with ampicillin, gentamicin and metronidazole
48. Antibiotic monotherapy with meropenem in the surgical management of intra-abdominal infections
49. A randomized controlled trial of ampicillin plus sulbactam vs. gentamicin plus clindamycin in the treatment of intra-abdominal infections: A preliminary report
50. A randomized clinical study of cefoperazone and sulbactam versus gentamicin and clindamycin in the treatment of intra-abdominal infections
51. Meropenem versus imipenem/cilastatin in the treatment of intra-abdominal infections requiring surgery
52. Antibiotic management of complicated appendicitis
53. The efficacy and safety of isepamicin compared with amikacin in the treatment of intra-abdominal infections
54. Treatment of acute bacterial peritonitis: A trial of imipenem/cilastatin against ampicillin-metronidazole-gentamicin
55. Stratified outcome comparison of clindamycin-gentamicin vs. chloramphenicol-gentamicin for treatment of intra-abdominal sepsis
56. Comparative study of cefotetan and cefoxitin in the treatment of intra-abdominal infections
57. Ceftriaxone/metronidazole is more effective than ampicillin/netilmicin/metronidazole in the treatment of bacterial peritonitis
58. Treatment of intra-abdominal infections is appropriate with single-agent or combination antibiotic therapy
59. Comparative study of parenteral piperacillin and cefoxitin in the treatment of surgical infections of the abdomen
60. Piperacillin/tazobactam versus imipenem/cilastatin in the treatment of intra-abdominal infections
61. Piperacillin compared with cefuroxime plus metronidazole in diffuse peritonitis
62. Imipenem versus tobramycin-antianaerobe antibiotic therapy in intra-abdominal infections
63. Prospective randomized study of piperacillin/tazobactam therapy of surgically treated intra-abdominal infection
64. A randomized multicentre trial of pefloxacin plus metronidazole and gentamicin plus metronidazole in the treatment of severe intra-abdominal infections
65. Comparison of cefuroxime and gentamicin in combination with metronidazole in the treatment of peritonitis due to perforation of the appendix
66. Aspoxicillin versus piperacillin in severe abdominal infections - A comparative phase III study
67. A randomized clinical trial of moxalactam alone versus tobramycin plus clindamycin in abdominal sepsis
68. Antibiotic therapy of perforated appendicitis in children: A comparison of amoxycillin/clavulanate with a combination of benzylpenicillin, netilmicin and metronidazole
69. A randomized clinical trial of ampicillin, gentamicin and clindamycin versus cefotaxime and clindamycin in children with ruptured appendicitis
70. A randomized trial of ticarcillin and clavulanate versus gentamicin and clindamycin in patients with complicated appendicitis
71. Prospective, randomized, double-blind comparison of metronidazole and tobramycin with clindamycin and tobramycin in the treatment of intra-abdominal sepsis
72. Moxalactam vs. tobramycin-clindamycin. A randomized trial in secondary peritonitis
73. Clinical comparison of antibiotic combinations in the treatment of peritonitis and related mixed aerobic-anaerobic surgical sepsis
74. Clinical comparison of cefotaxime with gentamicin plus clindamycin in the treatment of peritonitis and other soft-tissue infections
75. Ceftriaxone versus combined gentamicin and clindamycin for polymicrobial surgical sepsis
76. Randomized prospective study comparing moxalactam and cefoxitin with or without tobramycin for the treatment of serious surgical infections
77. Antibiotic treatment during surgery for diffuse peritonitis: A prospective randomized study comparing the effects of cefuroxime and of a cefuroxime and metronidazole combination
78. Cephalosporin therapy in intra-abdominal infections. A multicenter randomized, comparative study of cefotetan, moxalactam, and cefoxitin
79. The role of pseudomonas species in patients treated with ampicillin and sulbactam for gangrenous and perforated appendicitis
80. Prospective randomized study of two different doses of clindamycin admixed with gentamicin in the management of perforated appendicitis
81. A randomised prospective controlled study of ciprofloxacin with metronidazole versus amoxicillin/clavulanic acid with metronidazole in the treatment of intra-abdominal infection
82. Cefotaxime and metronidazole in severe intra-abdominal infection
83. Imipenem therapy for perforated and gangrenous appendicitis
84. Ticarcillin/clavulanate in the treatment of severe peritonitis
85. Efficacité et tolérance de l'imipenem/cilastatine dans le traitement adjuvant de la chirurgie des péritonites chez les patients âgés de plus de 70 ans
86. Bacterial peritonitis. Protecting the high-risk patient
87. Piperacillin-tazobactam treatment for severe intra-abdominal infections
88. Diffuse peritonitis treated with tobramycin and clindamycin. Bacteria in relation to preoperative duration of illness
89. Etude de l'efficacité et de la tolérance de l'imipenem/cilastatine utilisé en monothérapie dans le traitement adjuvant à la chirurgie des péritonites
90. High-dose tobramycin combined with clindamycin or lincomycin in the treatment of septic peritonitis and intra-abdominal sepsis
91. Clindamycin and carbenicillin in treatment of patients with intra-abdominal and female genital tract infections
92. Efficacy and safety of piperacillin/tazobactam in intra-abdominal infections
93. Intra-abdominal sepsis
94. Traitement antibiotique des péritonites
95. Considerations for therapy of mixed infections: Focus on intra-abdominal infection
96. Antimicrobial treatment of intra-abdominal infections
97. Antibiotics for the acute abdomen
98. Treatment of intra-abdominal infections
99. Antibiothérapie des péritonites
100. Intra-abdominal infection: A review
101. Antibiotics for prophylaxis and treatment of intra-abdominal infections
102. Therapeutic options in peritonitis
103. Wound and intra-abdominal infections: Microbiological considerations and approaches to treatment
104. Treatment of intra-abdominal infections: Worldwide clinical trials
105. Abdominal sepsis
106. Antimicrobial therapy of intra-abdominal sepsis
107. The evolving management of secondary peritonitis
108. Intra-abdominal infection
109. Advances in the diagnosis and treatment of intra-abdominal infection
110. Sulbactam/ampicillin followed by oral treatment with sultamicillin for medical and surgical infections
111. Imipenem/cilastatin in the treatment of serious bacterial infections
112. Prospective randomized comparison of imipenem monotherapy with imipenem plus netilmicin for treatment of severe infections in non neutropenic patients
113. Randomized trial of imipenem-cilastatin versus gentamicin plus clindamycin in the treatment of polymicrobial infections
114. Ornidazole versus clindamycin: Comparative evaluation in the treatment of 140 serious anaerobic infections
115. Imipenem/cilastatin vs. gentamicin/clindamycin for the treatment of moderate to severe infections in hospitalized patients
116. Prospective randomized comparison of imipenem-cilastatin and piperacillin-tazobactam in nosocomial pneumonia or peritonitis
117. Comparison of the activity of meropenem with that of other agents in the treatment of intra-abdominal, obstetric/gynecologic, and skin and soft tissue
118. Definition of the role of Enterococcus in intra-abdominal infection: Analysis of a prospective randomized trial
119. "Breakthrough" enterococcal septicemia in surgical patients
120. Enterococcal infections in surgical patients: The mystery continues
121. The life and times of the Enterococcus
122. Emergence of Enterococcus as a significant pathogen
123. Pathogenicity of the Enterococcus in surgical infections
124. Abdominal surgical wound infection is lowered with improved perioperative enterococcus and bacteroides therapy
125. Pathogenicity of enterococci in a rat model of fecal peritonitis
126. Investigation of the potential role of Enterococcus faecalis in the patho-physiology of experimental peritonitis
127. Multicentered study of cefoperazone for treatment of intra-abdominal infections and comparison of cefoperazone cefamandole and clindamycin plus gentamicin for treatment of appendicitis and peritonitis
128. Minimal antibiotic therapy after emergency abdominal surgery: A prospective study
129. Metronidazole in the treatment of intra-abdominal sepsis
130. Susceptibility of intra-abdominal isolates at operation: A predictor of postoperative infection